CVE:ZMD ZoomMed (ZMD) Stock Price, News & Analysis → Bombshell 2024 election documentary (From Porter & Company) (Ad) Free ZMD Stock Alerts C$0.02 +0.02 (+∞) (As of 10/4/2018) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.05Volume220,000 shsAverage Volume290,486 shsMarket CapitalizationC$2.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ZoomMed alerts: Email Address Ad Behind the Markets4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About ZoomMedZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.Read More ZMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZMD Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive ZMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZoomMed and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorComputer and Technology Industry Health Information Services Sub-IndustryN/A Current SymbolCVE:ZMD CUSIPN/A CIKN/A Webzoommedcorpo.com Phone+1-450-6785457FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesC$10,000.00 Price / Sales203.39 Cash FlowN/A Price / Cash FlowN/A Book ValueC($0.02) per share Price / Book-0.88Miscellaneous Outstanding Shares135,591,000Free FloatN/AMarket CapC$2.03 million OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Yves MarmetChairman, CEO & PresMs. Marie-Helene PinardCFO, VP of Operations & Fin., Sec. and DirectorMr. André MarmetVP of Corp. Bus.Key CompetitorsTinkerine StudiosCVE:TTDiSIGN Media SolutionsCVE:ISDRewardStream SolutionsCVE:REWRoute1CVE:ROINovra TechnologiesCVE:NVIView All Competitors ZMD Stock Analysis - Frequently Asked Questions How have ZMD shares performed in 2024? ZoomMed's stock was trading at C$0.02 on January 1st, 2024. Since then, ZMD shares have increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. How do I buy shares of ZoomMed? Shares of ZMD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:ZMD) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss Ratings“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZoomMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.